First Time Loading...

Kingworld Medicines Group Ltd
HKEX:1110

Watchlist Manager
Kingworld Medicines Group Ltd Logo
Kingworld Medicines Group Ltd
HKEX:1110
Watchlist
Price: 0.62 HKD 8.77% Market Closed
Updated: May 19, 2024

Kingworld Medicines Group Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kingworld Medicines Group Ltd
Operating Income Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Kingworld Medicines Group Ltd
HKEX:1110
Operating Income
¥78.7m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
10%
Sinopharm Group Co Ltd
HKEX:1099
Operating Income
¥22.3B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Income
¥8.5B
CAGR 3-Years
-1%
CAGR 5-Years
8%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Income
¥4.1B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
17%
C
China National Medicines Corp Ltd
SSE:600511
Operating Income
¥2.5B
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
20%
Huadong Medicine Co Ltd
SZSE:000963
Operating Income
¥3.8B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
14%

See Also

What is Kingworld Medicines Group Ltd's Operating Income?
Operating Income
78.7m CNY

Based on the financial report for Dec 31, 2023, Kingworld Medicines Group Ltd's Operating Income amounts to 78.7m CNY.

What is Kingworld Medicines Group Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
10%

Over the last year, the Operating Income growth was -2%. The average annual Operating Income growth rates for Kingworld Medicines Group Ltd have been 6% over the past three years , 4% over the past five years , and 10% over the past ten years .